Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 3, 1998, Pages 403-405

  Shapiro, Martin A ^a,b   Sesnie, Josephine C ^a   Desaty, Theodora M ^a   Griffin, Timothy J ^a   Heifetz, Carl L ^a  

^a PFIZER INC   (United States)

^b Micro Doc Consultants Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINAFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; DRUG EFFICACY; FEMALE; KIDNEY ABSCESS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; SUBCUTANEOUS DRUG ADMINISTRATION;

ABSCESS; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CEFTAZIDIME; CILASTATIN; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HALF-LIFE; IMIPENEM; KIDNEY; KIDNEY DISEASES; MICE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUINOLONES; TREATMENT OUTCOME;

EID: 0031899714     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.3.403     Document Type: Article

References (10)

1. Spencer, R. C. (1996). An 8 year microbe base survey of the epidemiology, frequency, and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. Journal of Antimicrobial Chemotherapy 37,295-301.
2. Centers for Disease Control. (1996). National Nosocomial Infections Surveillance Semiannual Report (December, 1996). Atlanta, GA. American Journal of Infection Control, in press.
3. Sanford, J. P., Gilbert, D. N. & Sande, M. A. (eds) (1996). Guide To Antimicrobial Therapy, 26th edn. Antimicrobial Therapy, Inc. Dallas, TX.
4. Cambau, E., Perani, E., Dib, C., Petinon, C., Trias, J. & Jarlier, V. (1995). Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem. Antimicrobial Agents and Chemotherapy 39,2248-52.
5. Cohen, M. A., Huband, M. D., Mailloux, G. B., Yoder, S. L, Roland, G. E. & Heifetz, C. L (1991). In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagnostic Microbiology and Infectious Diseases 14,245-58.
6. Sesnie, J. C., Courtney, C. L, Desaty, T. M., Griffin, T. J., Saby, J. A. & Heifetz, C. L (1991). In vivo efficacy of PD 127391 (CI-960) in a Pseudomonas aeruginosa mouse renal abscess model. In Program and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1991. Abstract 1153, p. 291. American Society for Microbiology, Washington, DC.
7. National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Second Edition. Approved Standard M7-A2. NCCLS, Villanova, PA.
8. Heifetz, C. L., Sesnie, J. C., Frey, C. A. & Fisher, M. W. (1975). A new procedure for inducing Pseudomonas pyelonephritis in mice. In Program and Abstracts of the Fifteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1975. Abstract 200. American Society for Microbiology, Washington, DC.
9. Shimizu, M., Sekine, Y., Higuchi, H., Suzuki, H. & Nakamura, S. (1970). Piromidic acid, a new antibacterial agent, absorption, distribution, excretion, and metabolism. Antimicrobial Agents and Chemotherapy 10,123-8.
10. Fernandes, P. B., Shipkowitz, N. L. & Bower, R. R. (1987). Murine models for studying the pathogenesis and treatment of pyelonephritis. Advances in Experimental Medicine and Biology 224, 35-51.